1040 - Growing Demand for Menopausal Hormone Therapies Brings Excitement—and New Concerns
Episode Description
Following the FDA's removal of black box warnings for hormone therapy drugs, demand has skyrocketed for menopause treatments. In this episode: why this explosion in popularity marks a trend in the right direction for quality reproductive care while also raising concerns about "menowashed" products and blanket prescribing of hormonal interventions.
Guests:Dr. Wendy L. Bennett, MPH, is a primary care doctor and associate professor with appointments at the Johns Hopkins Bloomberg School of Public Health and School of Medicine.
Dr. Tina Zhang is a primary care doctor and assistant professor at the Johns Hopkins University School of Medicine.
Host:Stephanie Desmon, MA, is a former journalist, author, and the director of public relations and communications for the Johns Hopkins Center for Communication Programs.
Show links and related content:-
Why the 'mad scramble' to fill hormone therapy prescriptions for menopause—NPR
-
FACT SHEET: FDA Initiates Removal of "Black Box" Warnings from Menopausal Hormone Replacement Therapy Products—U.S. Department of Health and Human Services
-
What Is a Black Box Warning?—Johns Hopkins Bloomberg School of Public Health
-
De-medicalizing Menopause—Public Health On Call (March 2024)
Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel.
Contact us:Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website.
Follow us:-
Here's our RSS feed
Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.
Listen On
